2014-01-24 23:26:31 - Fast Market Research recommends "Lithuania Pharmaceuticals & Healthcare Report Q1 2014" from Business Monitor International, now available
We expect the Lithuanian pharmaceutical market to post a five-year compound annual growth rate (CAGR) of 4.0%, rising to a value of LTL2.09bn (US$726mn) in 2017. While double-digit annual growth rates are firmly in the past, some opportunities continue to exist in light of epidemiological factors and an ageing population. However, finances will remain tight, both in terms of public and private spending on medicines and healthcare in general.
Headline Expenditure Projections
* Pharmaceuticals: LTL1.72bn (US$640mn) in 2012 to LTL1.74bn (US$672mn) in 2013; +1.5% in local currency terms and +5.1% in US dollar terms. Forecasts somewhat higher in relation to previous quarter on account of more positive macroeconomic outlook.
* Healthcare: LTL7.67bn (US$2.86bn) in 2012 to LTL7.57bn (US$2.92bn) in 2013;
-1.4% in local currency terms and +2.1% in US dollar terms. Forecasts somewhat higher in relation to previous quarter on account of more positive macroeconomic outlook.
Full Report Details at
- www.fastmr.com/prod/760707_lithuania_pharmaceuticals_healthcare_ ..
Risk/Reward Rating: Lithuania remains ranked in the bottom half of the table assessing 20 countries in the Central and Eastern Europe (CEE) region. We note that Lithuania's small population will continue to restrict longer-term opportunities in its pharmaceutical market, despite its solid risks profile and a predictable operating environment. We therefore hold to our view that Lithuania's overall Pharmaceutical Risk/Reward Rating (RRR) score will not change drastically over the coming quarters.
Key Trends and Developments
* Lithuanian companies recently showcased their life science products, skills and expertise in Israel as part of the June 2013 IATI-BIOMED 2013 exhibition. The companies that took part in the exhibition included Biotechpharma, MedSiNet LT, and Optolita.
* Israeli venture capital companies are reportedly actively seeking to invest in Lithuania's life sciences sector. The two countries have also recently signed a bilateral cooperation agreement in industrial research and development (R&D).
BMI Economic View: Improvement in household consumption and a strong export sector performance in H113 point to another year of fairly robust economic growth in Lithuania, prompting us to lift our full-year real GDP growth forecast from 2.6% to 3.4%. Despite anticipating a slight drop in household spending growth in 2014, we believe a gradual improvement in fixed investment and still strong export levels will see real GDP growth accelerate to 3.6%.
BMI Political View: Lithuania boasts a solid political risk profile, given the country's strong political institutions and history of stability in the post-Soviet era. Although the policy-making process can be fraught with coalition infighting and often weakened mandates, Lithuania receives a score of 66.7 out of 100 in the 'policy-making process' category of our short-term Political Risk Rating for the country. Despite fierce public opposition and a small parliamentary majority, the ousted former centre-right coalition government managed to pursue austerity measures, which have solidified public finances and ensured steady convergence with the eurozone in recent years.
Report Table of Contents:
The table of contents for this report is available upon request.
About Business Monitor International
Business Monitor International (BMI) offers a comprehensive range of products and services designed to help senior executives, analysts and researchers assess and better manage operating risks, and exploit business opportunities, across 175 markets. BMI offers three main areas of expertise: Country Risk BMI's country risk and macroeconomic forecast portfolio includes weekly financial market reports, monthly regional Monitors, and in-depth quarterly Business Forecast Reports. Industry Analysis BMI covers a total of 17 industry verticals through a portfolio of services, including in-depth quarterly Country Forecast Reports. View more research from Business Monitor International at www.fastmr.com/catalog/publishers.aspx?pubid=1010
About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.
For more information about these or related research reports, please visit our website at www.fastmr.com
or call us at 1.800.844.8156.